Omega Pharma NV (OME) may bid for European over-the-counter medicine brands that have been put up for sale by GlaxoSmithKline Plc (SAN), L’Echo reported, without saying where it got the information.

The buyer is expected to pay more than 250 million euros ($333.4 million) for the brands, the newspaper said.

To contact the reporter on this story: Jim Brunsden in Brussels at jbrunsden@bloomberg.net

To contact the editor responsible for this story Anthony Aarons at aaarons@bloomberg.net